There are various assays that are used in testing cytotoxicity including, MTT, MTS, ATP, Neutral Red, and Enzyme-linked Immunosorbent Assay (ELISA). In vitro toxicity testing finds application in the cosmetics, household products, pharmaceuticals, food and beverages, and chemicals sectors.
The global in vitro toxicity testing market is estimated to account for US$ 14,940.2 Mn in terms of value by the end of 2027.
Global In Vitro Toxicity Testing Market: Drivers
Emergence of pandemic diseases is expected to propel growth of the global in vitro toxicity testing market over the forecast period. For instance, the novel coronavirus disease (COVID-19) has spread in over 200 countries, affected around 2,883,603 people, and resulted in 198,842 deaths worldwide as of April 27, 2020, as reported to the World Health Organization.
Global In Vitro Toxicity Testing Market: Opportunities
Increasing prevalence of chronic disorders is expected to offer lucrative growth opportunities for players in the global in vitro toxicity market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Global In Vitro Toxicity Testing Market: Restraints
Limitations of in vitro toxicity testing are expected to hinder growth of the market. These limitations include, inclusion of xenobiotic metabolism into in vitro assays, capturing interactions between different cell types, and issues related to extrapolating from in vivo doses to in vitro concentrations.
The global in vitro toxicity testing market was valued at US$ 4,745.9 Mn in 2019 and is forecast to reach a value of US$ 14,940.2 Mn by 2027 at a CAGR of 15.4% between 2020 and 2027. Increasing prevalence of pandemic diseases is expected to propel growth of the global in vitro toxicity testing market over the forecast period.
Absorption segment held dominant position in the global in vitro toxicity testing market in 2019, accounting for 43.5% share in terms of value. Increasing prevalence of chronic disorders is expected to propell the growth of segment during the forecast period.
Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in April 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., a developer of instruments and consumables for the isolation, detection, and analysis of single cells.
Major players in the market are also focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in January 2020, Charles River Laboratories, Inc. partnered with Fios Genomics, a provider of bioinformatics data analysis services, under which Charles River Laboratories clients will have access to Fios Genomics’ expertise in multi-variant datasets associated with drug development including microarrays, next-generation sequencing (NGS), proteomics, metabolomics and epigenetics as well as the associated meta-data.
Global In Vitro Toxicity Testing Market: Competitive Landscape
Major players operating in the global in vitro toxicity testing market include, Bio-Rad Laboratories, Inc., Cyprotex, Charles River Laboratories International Inc., and Covance Inc.
Global In Vitro Toxicity Testing Market: Key Developments
Major players in the market are focused on adopting various marketing strategies to enhance their market share. For instance, in December 2019, Cyprotex announced to offer GIANTmicrobes mitochondria for every customer placing an order for vitro toxicology assays from January 2020 to March 2020.